Skip to content

AUTOLUS THERAPEUTICS PLC

AUTL

CIK 0001730463

← back to feed
Revenue (TTM)
$77.32M
+644.9% YoY Q1 May 2026
Net Income (TTM)
−$268.79M
−30.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.01
−25.6% YoY Q1 May 2026
Gross Margin
-23.7%
Q1 May 2026
Operating Margin
-333.2%
Q1 May 2026
Net Margin
-347.7%
Q1 May 2026
Free Cash Flow (TTM)
−$238.9M
Q1 May 2026
Cash
$130.93M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
266.16M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings